Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome

Metabolism: Clinical and Experimental

Volumn 60, Issue 4, 2011, Pages 564-568

  Namkung, Jun ^a   Koh, Sang Baek ^a   Kong, In Deok ^a   Choi, Jong Whan ^a   Yeh, Byung Il ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RELATED GROWTH FACTOR; CREATININE; GLUCOSE; GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SOUTH KOREA; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGE FACTORS; AGED; ANGIOPOIETINS; ANTHROPOMETRY; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; FEMALE; HEMODYNAMICS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REGRESSION ANALYSIS; REPUBLIC OF KOREA; RURAL POPULATION; SEX FACTORS; UP-REGULATION; WAIST CIRCUMFERENCE;

EID: 79952993729     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.05.013     Document Type: Article

References (32)

1. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
2. Lakka H.M., Laaksonen D.E., and Lakka T.A. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716 (Pubitemid 35403784)
3. Oda E. The metabolic syndrome as a concept of adipose tissue disease Hypertens Res 31 2008 1283 1291
4. Perez-Tilve D., Stern J.E., and Tschop M. The brain and the metabolic syndrome: not a wireless connection Endocrinology 147 2006 1136 1139 (Pubitemid 43244344)
5. Forst T., Hohberg C., and Pfutzner A. Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients Horm Metab Res 41 2009 123 131
6. Nistala R., and Stump C.S. Skeletal muscle insulin resistance is fundamental to the cardiometabolic syndrome J Cardiometab Syndr 1 2006 47 52
7. Meshkani R., and Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease Clin Biochem 2009
8. Rabe K., Lehrke M., and Parhofer K.G. Adipokines and insulin resistance Mol Med 14 2008 741 751
9. Patel S.B., Reams G.P., and Spear R.M. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease Curr Hypertens Rep 10 2008 131 137
10. Lara-Castro C., Fu Y., and Chung B.H. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease Curr Opin Lipidol 18 2007 263 270 (Pubitemid 46743049)
11. Wolf G. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes Nutr Rev 65 2007 251 256 (Pubitemid 351804369)
12. Kim J.H., Bachmann R.A., and Chen J. Interleukin-6 and insulin resistance Vitam Horm 80 2009 613 633
13. Cederberg A., and Enerback S. Insulin resistance and type 2 diabetes-an adipocentric view Curr Mol Med 3 2003 107 125 (Pubitemid 36285100)
14. Bays H., Blonde L., and Rosenson R. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? Expert Rev Cardiovasc Ther 4 2006 871 895 (Pubitemid 46017525)
15. Petruzzelli M., Lo Sasso G., and Portincasa P. Targeting the liver in the metabolic syndrome: evidence from animal models Curr Pharm Des 13 2007 2199 2207 (Pubitemid 47074053)
16. Bahr M.J., Boeker K.H., and Manns M.P. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis Clin Endocrinol (Oxf) 70 2009 60 65
17. Hato T., Tabata M., and Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism Trends Cardiovasc Med 18 2008 6 14
18. Oike Y., Akao M., and Yasunaga K. Angiopoietin-related growth factor antagonizes obesity and insulin resistance Nat Med 11 2005 400 408 (Pubitemid 40562330)
19. Kitazawa M., Ohizumi Y., and Oike Y. Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt/forkhead box class O1-dependent pathway in hepatocytes J Pharmacol Exp Ther 323 2007 787 793 (Pubitemid 350146061)
20. Stepan H., Ebert T., and Schrey S. Serum levels of angiopoietin-related growth factor are increased in preeclampsia Am J Hypertens 22 2009 314 318
21. Ebert T., Bachmann A., and Lossner U. Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis Metabolism 58 2009 547 551
22. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
23. Lee S.Y., Park H.S., and Kim D.J. Appropriate waist circumference cutoff points for central obesity in Korean adults Diabetes Res Clin Pract 75 2007 72 80 (Pubitemid 44856015)
24. Oike Y., Yasunaga K., and Ito Y. Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling, and regeneration Proc Natl Acad Sci U S A 100 2003 9494 9499 (Pubitemid 37033956)
25. Oike Y., Yasunaga K., and Suda T. Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis Int J Hematol 80 2004 21 28 (Pubitemid 38937871)
26. Zhang Y., Hu X., and Tian R. Angiopoietin-related growth factor (AGF) supports adhesion, spreading, and migration of keratinocytes, fibroblasts, and endothelial cells through interaction with RGD-binding integrins Biochem Biophys Res Commun 347 2006 100 108 (Pubitemid 44015655)
27. Kersten S. Regulation of lipid metabolism via angiopoietin-like proteins Biochem Soc Trans 33 2005 1059 1062 (Pubitemid 41659113)
28. Oike Y., Akao M., and Kubota Y. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy Trends Mol Med 11 2005 473 479 (Pubitemid 41415727)
29. George J. Angiopoietin-like proteins: another player in the metabolic field J Hepatol 44 2006 832 834
30. Kim E.S., Han S.M., and Kim Y.I. Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea Diabet Med 21 2004 1141 1143 (Pubitemid 39389228)
31. Choi S.H., Ahn C.W., and Cha B.S. The prevalence of the metabolic syndrome in Korean adults: comparison of WHO and NCEP criteria Yonsei Med J 46 2005 198 205 (Pubitemid 40662971)
32. Muoio D.M., and Newgard C.B. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes Nat Rev Mol Cell Biol 9 2008 193 205 (Pubitemid 351301824)